Gilead Sciences Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Gilead Sciences Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Gilead Sciences Inc. stocks after a simple registration process. </div>

Q: How to buy Gilead Sciences Inc. shares in India?

<div> To buy Gilead Sciences Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Gilead Sciences Inc. and you are done!</div> </div>

Q: What is the share price of Gilead Sciences Inc.?

<div>The share price of Gilead Sciences Inc. is USD 91.48 as on 18 Dec.</div>

Q: What is the Market Capitalization of Gilead Sciences Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Gilead Sciences Inc. is USD 114.01B as on 18 Dec.</div>

Q: What is the PE ratio of Gilead Sciences Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Gilead Sciences Inc. is 1022.78 as on 18 Dec. </div>

Q: Is Gilead Sciences Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Gilead Sciences Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Gilead Sciences Inc. operate?

<div> Gilead Sciences Inc. operates in Healthcare / Drug manufacturers - general

Healthcare Drug manufacturers - general

$91.48

-1.29

(18 Dec)

Loading Chart

Previous close

$91.48

Open

$91.48

Today’s high

$93.50

Today’s low

$91.12

52W low

$60.24

52W high

$98.0756

15.03%

6.84%

1022.78

Div yield

3.35%

EPS (TTM)

0.09

Shares O/S

1.25B

Market cap

114.01B

Insights

GILD price is below its 200 day moving average

GILD PE is in the top end of its range over the past 2 years

GILD PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

About Gilead Sciences Inc.

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need.

Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries. .

FAQs

Can I buy Gilead Sciences Inc. shares in India?

How to buy Gilead Sciences Inc. shares in India?

What is the share price of Gilead Sciences Inc.?

What is the Market Capitalization of Gilead Sciences Inc.?

What is the PE ratio of Gilead Sciences Inc.?

Is Gilead Sciences Inc. a good stock to buy?

In which sector / industry does Gilead Sciences Inc. operate?